262 related articles for article (PubMed ID: 19263232)
1. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany.
Kaatsch P; Reinisch I; Spix C; Berthold F; Janka-Schaub G; Mergenthaler A; Michaelis J; Blettner M
Cancer Causes Control; 2009 Aug; 20(6):965-80. PubMed ID: 19263232
[TBL] [Abstract][Full Text] [Related]
2. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study.
Guérin S; Hawkins M; Shamsaldin A; Guibout C; Diallo I; Oberlin O; Brugières L; de Vathaire F
J Clin Oncol; 2007 Jul; 25(19):2833-9. PubMed ID: 17602088
[TBL] [Abstract][Full Text] [Related]
3. Incidence and susceptibility to therapy-related myeloid neoplasms.
Leone G; Fianchi L; Pagano L; Voso MT
Chem Biol Interact; 2010 Mar; 184(1-2):39-45. PubMed ID: 20026017
[TBL] [Abstract][Full Text] [Related]
4. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
5. Leukemia incidence following primary breast carcinoma treatment.
Kaplan HG; Malmgren JA; Atwood M
Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
[TBL] [Abstract][Full Text] [Related]
6. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
7. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
8. Secondary neoplasms after radiotherapy for a childhood solid tumor.
Paulino AC; Fowler BZ
Pediatr Hematol Oncol; 2005 Mar; 22(2):89-101. PubMed ID: 15804994
[TBL] [Abstract][Full Text] [Related]
9. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study.
Guérin S; Guibout C; Shamsaldin A; Dondon MG; Diallo I; Hawkins M; Oberlin O; Hartmann O; Michon J; Le Deley MC; de Vathaire F
Int J Cancer; 2007 Jan; 120(1):96-102. PubMed ID: 17013899
[TBL] [Abstract][Full Text] [Related]
10. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries.
Svahn-Tapper G; Garwicz S; Anderson H; Shamsaldin A; De Vathaire F; Olsen JH; Døllner H; Hertz H; Jonmundsson G; Langmark F; Lanning M; Sankila R; Tulinius H; Möller T
Acta Oncol; 2006; 45(4):438-48. PubMed ID: 16760180
[TBL] [Abstract][Full Text] [Related]
12. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
13. Leukemia as a second malignancy.
Uppin MS; Paul TR; Rajappa S; Gayathri K; Jacob R; Uppin SG
Indian J Pathol Microbiol; 2007 Jul; 50(3):644-7. PubMed ID: 17883171
[TBL] [Abstract][Full Text] [Related]
14. An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors.
Peterson KM; Shao C; McCarter R; MacDonald TJ; Byrne J
Pediatr Blood Cancer; 2006 Jul; 47(1):83-8. PubMed ID: 16317732
[TBL] [Abstract][Full Text] [Related]
15. Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease.
Hoppe RT
Leukemia; 1992 Nov; 6 Suppl 4():155-7. PubMed ID: 1434819
[No Abstract] [Full Text] [Related]
16. Myelodysplastic syndrome and acute leukaemia following treatment of soft tissue sarcoma.
de Graeff A; Vendrik CP; Pinedo HM
Neth J Med; 1989 Jun; 34(5-6):251-7. PubMed ID: 2671758
[TBL] [Abstract][Full Text] [Related]
17. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
Nguyen F; Rubino C; Guerin S; Diallo I; Samand A; Hawkins M; Oberlin O; Lefkopoulos D; De Vathaire F
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):908-15. PubMed ID: 18262102
[TBL] [Abstract][Full Text] [Related]
18. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
Kaplan H; Malmgren J; De Roos AJ
Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
[TBL] [Abstract][Full Text] [Related]
19. Secondary myelodysplastic syndrome after small cell lung cancer and esophageal cancer.
Otsuka Y; Konishi T; Nara S; Furushima K; Nakajima K; Shimada H
J Gastroenterol Hepatol; 2005 Sep; 20(9):1318-21. PubMed ID: 16105115
[TBL] [Abstract][Full Text] [Related]
20. Risk of melanoma following adulthood cancer: a case-control study.
Dupuy A; Shamsaldin A; Quiniou E; Paoletti C; Labbé M; Avril MF; Lefkopoulos D; de Vathaire F
Eur J Cancer; 2005 Dec; 41(18):2904-10. PubMed ID: 16243516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]